Inhibition of protein kinase CK2 with the clinicalgrade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity.
Saved in:
| Title: | Inhibition of protein kinase CK2 with the clinicalgrade small ATP-competitive compound CX-4945 or by RNA interference unveils its role in acute myeloid leukemia cell survival, p53-dependent apoptosis and daunorubicin-induced cytotoxicity. |
|---|---|
| Authors: | Tubi, Laura Quotti1 squoz82@libero.it, Gurrieri, Carmela1 carmela.gurrieri@unipd.it, Brancalion, Alessandra1 ale.branca@yahoo.it, Bonaldi, Laura2 laura.bonaldi@unipd.it, Bertorelle, Roberta2 roberta.bertorelle@unipd.it, Manni, Sabrina1 sabrina.manni@unipd.it, Pavan, Laura1 laura.pavan@unipd.it, Lessi, Federica1, Zambello, Renato1 r.zambello@unipd.it, Trentin, Livio1 livio.trentin@unipd.it, Adami, Fausto1 f.adami@unipd.it, Ruzzene, Maria3 maria.ruzzene@unipd.it, Pinna, Lorenzo A.3 lorenzo.pinna@unipd.it, Semenzato, Gianpietro1 g.semenzato@unipd.it |
| Source: | Journal of Hematology & Oncology. 2013, Vol. 6 Issue 1, p1-30. 30p. |
| Database: | Academic Search Ultimate |
| ISSN: | 17568722 |
|---|---|
| DOI: | 10.1186/1756-8722-6-78 |
